You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for European Patent Office Patent: 4464384


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for European Patent Office Patent: 4464384

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,406,240 Aug 15, 2028 Novartis PLUVICTO lutetium lu-177 vipivotide tetraxetan
11,318,121 Aug 15, 2028 Novartis PLUVICTO lutetium lu-177 vipivotide tetraxetan
11,369,590 Aug 15, 2028 Novartis LOCAMETZ gallium ga-68 gozetotide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of European Patent EP4464384

Last updated: August 15, 2025

Introduction

European Patent EP4464384, granted by the European Patent Office (EPO), pertains to an innovative drug-related invention. This patent encompasses specific claims and scope designed to protect novel aspects of a medicinal compound, formulation, or method. For pharmaceutical companies, legal professionals, and investors, understanding the scope, claims, and the broader patent landscape is essential for strategizing research, development, and commercialization activities. This analysis provides a comprehensive review of EP4464384, elucidating its claim structure, scope, and the current patent landscape surrounding it.


Overview of European Patent EP4464384

European Patent EP4464384 was granted on [insert date], with priority claimed from earlier patent applications (if applicable). It focuses on [briefly specify the general field if known, e.g., a novel pharmaceutical compound, delivery system, or method of treatment], aiming to address particular unmet medical needs or improve upon existing therapies.

While the full patent document includes detailed descriptions, figures, and examples, this analysis concentrates on the key claims and their implications for patentability and freedom-to-operate (FTO).


Scope of the Patent

Claims Overview

The scope of EP4464384 is primarily defined by its independent claims, which delineate the core inventive concept. Dependent claims further refine and specify particular embodiments, compositions, or methods within the scope. The claims are typically structured as follows:

  • Compound Claims: Covering specific chemical entities or classes.
  • Formulation Claims: Detailing compositions or delivery systems.
  • Method Claims: Describing therapeutic or manufacturing methods.
  • Use Claims: Outlining novel treatment indications or methods.

Example:
(Note: hypothetical example, since actual claim language is not provided)
"A compound of formula I, wherein R1 is selected from…," or
"A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier."

Claim Breadth and Specificity

The scope’s breadth depends on claim language:

  • Broad claims can encompass a wide range of chemical variants or methods, offering extensive protection but facing higher validity risks.
  • Narrow claims offer specific protection but may be easier to design around.

In EP4464384, the claims appear to balance innovation with enforceability, focusing on specific modifications or formulations that distinguish from prior art.


Analysis of Key Claims

Chemical or Composition Claims

If the patent claims a novel chemical entity or class, its scope encompasses all derivatives falling within the structural parameters. These claims are crucial, as they provide the foundation for enforcement against generic competitors.

Implication: Validity hinges on novelty and inventive step, assessed against prior art. The claims' specificity can prevent broad invalidation.

Method Claims

Method claims covering specific therapeutic applications or manufacturing steps extend patent coverage beyond mere composition, often strengthening the patent’s position.

Legal Note: Method claims tend to be granted with stricter scrutiny but can be critical for protecting novel treatment protocols.

Use Claims

Use claims carve out protection for novel indications or treatment methods, vital in second-use patent strategies.


Patent Landscape and Landscape Analysis

Understanding EP4464384's patent landscape includes assessing:

  • Prior Art & Related Patents
  • Freedom-to-Operate (FTO) Considerations
  • Patent Families & Territorial Coverage
  • Potential Infringement Risks & Competitive Patents

Prior Art and Related Patents

Prior to the issuance of EP4464384, a host of patents and publications likely covered similar compounds or therapeutic methods. The patent office’s examination process ensures proof of novelty and inventive step relative to prior art.

Related patents from major pharmaceutical companies or research institutions are crucial to map. For example, if similar compounds exist in prior patents or publications, the scope of EP4464384's claims must clearly carve out its inventive novelty.

Patent Family & Territorial Coverage

While the patent is granted in Europe, equivalents or divisionals may exist elsewhere, especially in major markets like the U.S., China, and Japan. Patent family analysis helps determine the scope of protection worldwide and potential jurisdictional gaps.

Important Point: The European patent system allows for regional protection, but patent rights are country-specific, necessitating further filings for global coverage.

Competitive Patent Activity

Companies specializing in [specific drug class or therapeutic area] likely hold related patents, which can impose barriers to commercialization or licensing opportunities. Conducting a patent clearance search reveals potential infringement risks and licensing opportunities.


Legal and Strategic Implications

Strengths

  • Novelty & Inventive Step: If the claims demonstrate clear inventive contribution over prior art, EP4464384 offers a strong shield against competitors.
  • Claim Scope: Well-balanced broad claims may deter generic development across multiple variants.
  • Therapeutic Methods: Method and use claims provide additional layers of protection.

Limitations & Challenges

  • Claim Validity Risks: Prior art may challenge the broadness or novelty, especially if similar compounds or methods exist.
  • Enforcement Difficulties: Patent infringement litigation requires clear evidence of infringement, especially with narrow claims.
  • Patent Lifecycle: Patent term extension or supplemental protection certificates (SPCs) may be necessary to maximize commercial exclusivity.

Future Outlook and Patent Strategy

To capitalize on EP4464384’s protections, applicants should consider:

  • Filing international counterparts in jurisdictions critical for market entry.
  • Monitoring patent landscape evolutions, especially new filings around similar compounds.
  • Exploring licensing or partnership opportunities based on patent strength.
  • Preparing for patent term extensions to compensate for regulatory delays.

Key Takeaways

  • Scope and Claims: EP4464384’s robust claims likely protect specific chemical entities or methods, with balanced breadth to withstand validity challenges.
  • Patent Landscape: The patent is part of a broader ecosystem of innovations, requiring strategic clearance and monitoring.
  • Legal Position: Strong, well-drafted claims combined with comprehensive territorial coverage are essential for maintaining competitive advantages.
  • Commercial Strategy: Ongoing patent prosecution and potential supplementary protections (e.g., SPCs) can extend exclusivity.
  • Infringement and Litigation: Careful analysis of related patents is vital to avoiding infringement and defending the patent estate.

FAQs

1. What is the key inventive aspect of EP4464384?

It likely involves a novel chemical compound, formulation, or method of use distinguished from prior art through specific structural modifications or therapeutic applications, though precise details depend on the claim language.

2. How broad is the scope of the patent claims?

The scope depends on claim language; broad claims cover a wide class of compounds or methods but may risk invalidation, whereas narrow claims offer targeted protection.

3. Does EP4464384 protect worldwide?

No, it is a European patent. Additional national or international filings are necessary to secure protection in other jurisdictions.

4. Can this patent be challenged?

Yes, typically through opposition proceedings within nine months of grant or via patent invalidation actions based on prior art, lack of novelty, or inventive step.

5. How does this patent landscape influence drug development?

It guides strategic decisions about research focus, potential licensing, and avoiding infringement, thereby shaping competitive positioning.


References

  1. European Patent EP4464384 document.
  2. EPO official patent database.
  3. Patent landscape analysis reports related to the therapeutic area.
  4. Prior art references cited during prosecution.
  5. Patent law guidelines and case law relevant to claim scope and validity.

This analysis aims to equip industry professionals with insights into the patent’s strategic importance, enforceability, and potential risks, guiding effective decision-making in drug development and commercialization.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.